720 related articles for article (PubMed ID: 19351822)
21. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
22. ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup Medulloblastomas.
Grausam KB; Dooyema SDR; Bihannic L; Premathilake H; Morrissy AS; Forget A; Schaefer AM; Gundelach JH; Macura S; Maher DM; Wang X; Heglin AH; Ge X; Zeng E; Puget S; Chandrasekar I; Surendran K; Bram RJ; Schüller U; Talyor MD; Ayrault O; Zhao H
Cancer Res; 2017 Jul; 77(14):3766-3777. PubMed ID: 28490517
[TBL] [Abstract][Full Text] [Related]
23. Sonic Hedgehog Signaling Drives Mitochondrial Fragmentation by Suppressing Mitofusins in Cerebellar Granule Neuron Precursors and Medulloblastoma.
Malhotra A; Dey A; Prasad N; Kenney AM
Mol Cancer Res; 2016 Jan; 14(1):114-24. PubMed ID: 26446920
[TBL] [Abstract][Full Text] [Related]
24. c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice.
Rao G; Pedone CA; Coffin CM; Holland EC; Fults DW
Neoplasia; 2003; 5(3):198-204. PubMed ID: 12869303
[TBL] [Abstract][Full Text] [Related]
25. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
[TBL] [Abstract][Full Text] [Related]
26. Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
Murphy BL; Obad S; Bihannic L; Ayrault O; Zindy F; Kauppinen S; Roussel MF
Cancer Res; 2013 Dec; 73(23):7068-78. PubMed ID: 24145352
[TBL] [Abstract][Full Text] [Related]
27. Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma.
Bharambe HS; Joshi A; Yogi K; Kazi S; Shirsat NV
Acta Neuropathol Commun; 2020 May; 8(1):70. PubMed ID: 32410663
[TBL] [Abstract][Full Text] [Related]
28. The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.
Vo BT; Wolf E; Kawauchi D; Gebhardt A; Rehg JE; Finkelstein D; Walz S; Murphy BL; Youn YH; Han YG; Eilers M; Roussel MF
Cancer Cell; 2016 Jan; 29(1):5-16. PubMed ID: 26766587
[TBL] [Abstract][Full Text] [Related]
29. Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma.
Bhatia B; Potts CR; Guldal C; Choi S; Korshunov A; Pfister S; Kenney AM; Nahlé ZA
Acta Neuropathol; 2012 Apr; 123(4):587-600. PubMed ID: 22407012
[TBL] [Abstract][Full Text] [Related]
30. The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma.
Uziel T; Karginov FV; Xie S; Parker JS; Wang YD; Gajjar A; He L; Ellison D; Gilbertson RJ; Hannon G; Roussel MF
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2812-7. PubMed ID: 19196975
[TBL] [Abstract][Full Text] [Related]
31. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.
Hatton BA; Knoepfler PS; Kenney AM; Rowitch DH; de Alborán IM; Olson JM; Eisenman RN
Cancer Res; 2006 Sep; 66(17):8655-61. PubMed ID: 16951180
[TBL] [Abstract][Full Text] [Related]
32. The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity.
Smit MJ; Martini TEI; Armandari I; Bočkaj I; Zomerman WW; de Camargo Magalhães ES; Siragna Z; Meeuwsen TGJ; Scherpen FJG; Schoots MH; Ritsema M; den Dunnen WFA; Hoving EW; Paridaen JTML; de Haan G; Guryev V; Bruggeman SWM
J Cell Sci; 2022 Jun; 135(11):. PubMed ID: 35535520
[TBL] [Abstract][Full Text] [Related]
33. The miR-183∼96∼182 cluster promotes tumorigenesis in a mouse model of medulloblastoma.
Zhang Z; Li S; Cheng SY
J Biomed Res; 2013 Nov; 27(6):486-94. PubMed ID: 24285947
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
[TBL] [Abstract][Full Text] [Related]
35. Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas.
Kunder R; Jalali R; Sridhar E; Moiyadi A; Goel N; Goel A; Gupta T; Krishnatry R; Kannan S; Kurkure P; Deopujari C; Shetty P; Biyani N; Korshunov A; Pfister SM; Northcott PA; Shirsat NV
Neuro Oncol; 2013 Dec; 15(12):1644-51. PubMed ID: 24203893
[TBL] [Abstract][Full Text] [Related]
36. Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling in a mouse model of medulloblastoma.
Coon V; Laukert T; Pedone CA; Laterra J; Kim KJ; Fults DW
Mol Cancer Ther; 2010 Sep; 9(9):2627-36. PubMed ID: 20807782
[TBL] [Abstract][Full Text] [Related]
37. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R
PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736
[TBL] [Abstract][Full Text] [Related]
38. Role of MXD3 in proliferation of DAOY human medulloblastoma cells.
Barisone GA; Ngo T; Tran M; Cortes D; Shahi MH; Nguyen TV; Perez-Lanza D; Matayasuwan W; Díaz E
PLoS One; 2012; 7(7):e38508. PubMed ID: 22808009
[TBL] [Abstract][Full Text] [Related]
39. The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumors.
Mille F; Tamayo-Orrego L; Lévesque M; Remke M; Korshunov A; Cardin J; Bouchard N; Izzi L; Kool M; Northcott PA; Taylor MD; Pfister SM; Charron F
Dev Cell; 2014 Oct; 31(1):34-47. PubMed ID: 25263791
[TBL] [Abstract][Full Text] [Related]
40. MiR-34a deficiency accelerates medulloblastoma formation in vivo.
Thor T; Künkele A; Pajtler KW; Wefers AK; Stephan H; Mestdagh P; Heukamp L; Hartmann W; Vandesompele J; Sadowski N; Becker L; Garrett L; Hölter SM; Horsch M; Calzada-Wack J; Klein-Rodewald T; Racz I; Zimmer A; Beckers J; Neff F; Klopstock T; De Antonellis P; Zollo M; Wurst W; Fuchs H; Gailus-Durner V; Schüller U; de Angelis MH; Eggert A; Schramm A; Schulte JH
Int J Cancer; 2015 May; 136(10):2293-303. PubMed ID: 25348795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
